NanoViricides, Inc. (NNVC) Financials
NNVC Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-12-31 | 13.4 million | 951074 |
2023-09-30 | 16.9 million | 2.0 million |
2023-06-30 | 16.9 million | 2.0 million |
2023-03-31 | 18.6 million | 348744 |
NNVC Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-12-31 | -1.7 million | 47608 |
2023-09-30 | -1.5 million | 50455 |
2023-06-30 | -1.5 million | 50455 |
2023-03-31 | -1.8 million | 60305 |
NNVC Net Income
No data available :(
NNVC Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-12-31 | 5.2 million | - | - |
2023-09-30 | 8.1 million | - | - |
2023-06-30 | - | - | - |
2023-03-31 | 9.7 million | - | - |
NNVC Shares Outstanding
NNVC Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-12-31 | 5474 | 1.6 million | 610877 | -189330 |
2023-09-30 | 2566 | 2.9 million | 763422 | - |
2023-06-30 | 2566 | 2.9 million | 763422 | - |
2023-03-31 | 59301 | 1.2 million | 614647 | - |
NNVC Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2023-12-31 | - | 189330 |
2023-09-30 | - | 188882 |
2023-06-30 | - | - |
2023-03-31 | - | 188322 |
NNVC
Price: $1.13
52 week price:
Earnings Per Share: -0.80 USD
P/E Ratio: -1.52
Exchange: ASE
Sector: Healthcare
Industry: Biotechnology
Volume: 10400
Market Capitalization: 13.4 million